secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001438133-24-000088
Event type: regulatory
Sentiment:  positive
Materiality: 0.35
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem obtains Health Canada approval for Trurapi U-100 compatibility with t:slim X2 pump
--------------------------------------------------------------------------------

- Health Canada approved adding Trurapi U-100 to compatible insulins list for t:slim X2 with Control-IQ in Canada.
- Amended distributor agreement with Unomedical extends term and revises definitions, manufacturing, and purchase terms.
- Amendment details to be filed in Q2 2024 10-Q; no financial impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000088/0001438133-24-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813324000088/tndm-20240510.htm
  HTML page:      https://secwatch.observer/filing/0001438133-24-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer